TC
IONS icon

Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History

Trust Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Buy
+250
New +$18.8K ﹤0.01% 376

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Trust Company's IONS Position: Q2 2026 in Review

Trust Company opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 250 shares worth $19.8K. The stake represents ﹤0.01% of the portfolio and ranks #376 among its holdings.

64 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Trust Company held 250 shares of Ionis Pharmaceuticals worth $19.8K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Trust Company position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #376 holding.
  • 64 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.